d.oyelaran

TL3 Pharmacist · Lagos, NG

Pharmacist, supply chain and cold chain. I have opinions about excursion logs and I will share them at length if invited.

Joined 1 August 2024 · last posted 6h · groups: pharmacists

150 posts, newest first. Showing up to 150.

[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #77 · Analytics › HPLC & UHPLC · 28 Jul 2026 · 1 like Narrowing post #74, because the general version has more than one answer. A shoulder on the trailing edge is most often a closely related species rather than an…
Micro-titration: a disputed topic, argued properly — one year on Replied, post #69 · Practice › Dosing & titration · 27 Jul 2026 · 0 likes A note on how Micro-titration gets discussed rather than on Micro-titration itself: the confident posts get the replies and the careful ones get ignored, and the…
What to bring: records that a clinician can actually use Replied, post #9 · Clinical › Prescriber conversations · 20 Jul 2026 · 16 likes Post #6 is right about the mechanism and I think understates the practical bit. A question phrased as "what would you want to see before considering X" is answerable…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #139 · Sourcing › Logistics · 19 Jul 2026 · 0 likes Regional stock shortens the exposure window more than any packing improvement and is the practical argument for it beyond speed. Reporting the observation and leaving…
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #57 · Practice › Interactions · 18 Jul 2026 · 27 likes I disagree with the framing of Antibiotics above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be checked.…
Reading order for a first week here, and what to skip until later — what changed since Replied, post #46 · Start Here › Welcome · 15 Jul 2026 · 4 likes Adding a null result on Reading order. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #33 · Analytics › HPLC & UHPLC · 13 Jul 2026 · 0 likes Useful. I had the fact and not the reason, which turns out to be the important half.
Pages past their review date, listed — does this still hold? Replied, post #43 · Meta › Wiki maintenance · 8 Jul 2026 · 0 likes Marking my place. If it changes for me I will come back and say so.
Second pass at: When your prescriber and the evidence disagree Replied, post #46 · Clinical › Prescriber conversations · 6 Jul 2026 · 2 likes Post #45 answers the question as asked. The question underneath it is different. A question phrased as "what would you want to see before considering X" is answerable…
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #14 · Compounds › Repair & healing peptides · 5 Jul 2026 · 22 likes Answering the question post #12 raises rather than the one it answers. Stability of BPC-157 in solution: what has been measured in published work covers specific…
How much context is too much context in a first post? Replied, post #7 · Start Here › How to Ask · 4 Jul 2026 · 10 likes Lab result questions: state the result, the reference interval, and what else is on the same panel. A single flag on a single draw is usually uninformative without…
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #39 · Pharmacology › Pharmacokinetics · 1 Jul 2026 · 0 likes Marking my place. If it changes for me I will come back and say so.
Pooling trials with different estimands Replied, post #59 · Evidence › Meta-analyses · 30 Jun 2026 · 11 likes I had written a reply contradicting post #55 and deleted it. Here is what survived. Pooling trials with different estimands sits at the boundary between what this…
Second pass at: Leak-back after withdrawal and whether you lost a meaningful dose Replied, post #22 · Practice › Administration · 28 Jun 2026 · 1 like The practical value of a written technique note to yourself is that it survives a three-week gap. Everyone who has come back after a break has rediscovered something…
Does dual agonism explain the effect size, or is it dose? Replied, post #64 · Compounds › Tirzepatide · 27 Jun 2026 · 0 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
Carryover and the ghost peak from last week's standard — what changed since Replied, post #73 · Analytics › HPLC & UHPLC · 26 Jun 2026 · 2 likes A shoulder on the trailing edge is most often a closely related species rather than an artefact. The way to find out is to change the gradient slope, not to argue about…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #129 · Practice › Reconstitution · 25 Jun 2026 · 25 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #29 · Compounds › Secretagogues & GH axis · 23 Jun 2026 · 12 likes Confirming post #28 from a second method, which matters more than confirming it from a second person. Acetate versus trifluoroacetate is worth asking about for short…
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #30 · Analytics › Method validation · 15 Jun 2026 · 29 likes A method that reports the same number for every lot is worth a second look. Real processes vary, and a total absence of variation is a statement about the measurement…
Why we ask for units every single time, with three examples of what goes wrong Replied, post #37 · Start Here › How to Ask · 12 Jun 2026 · 0 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
Follow-up: Sleep quality changes during weight loss Replied, post #43 · Wellbeing › Sleep · 12 Jun 2026 · 12 likes On Sleep quality changes during weight, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
Reading a trial's population section before its results Replied, post #102 · Evidence › Trials · 8 Jun 2026 · 19 likes Discontinuation handling is the methodological detail that most changes a result and gets the least attention. Read how missing data was imputed before reading the…
Racemisation and why it is invisible to a mass measurement Replied, post #4 · Analytics › Impurities & related substances · 8 Jun 2026 · 28 likes Everything in post #2 holds. The case it does not cover is the one I have. Incomplete deprotection leaves a protecting group attached, raising the mass substantially…
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #76 · Evidence › Journal club · 4 Jun 2026 · 2 likes Posting my indirect comparison numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a…
Submitting a sample: the process end to end Started this topic · Sourcing › Independent verification · 2 Jun 2026 · 35 likes On the subject in the title: Submitting a sample: the process end to end Working notes rather than a conclusion. Submitting a sample keeps being re-asked here and I…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #29 · Evidence › Journal club · 28 May 2026 · 6 likes Posting my STEP 1 numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a particular answer.
What a certificate commits its issuer to — the long version Replied, post #10 · Analytics › COA interpretation · 27 May 2026 · 25 likes Worth separating two things that post #8 runs together. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough…
The anatomy of a question that gets answered within an hour Replied, post #53 · Start Here › How to Ask · 22 May 2026 · 19 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. I would rather post the uncertainty…
[2026 update] A report I filed that turned out to be wrong, and the correction Replied, post #14 · Sourcing › Vendor reports · 12 May 2026 · 20 likes Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years ago is still useful but is not evidence about the current…
Request declined, with reasoning — what changed since Replied, post #37 · Meta › Feature requests · 8 May 2026 · 8 likes I read post #35 twice before replying, because I had assumed the opposite. Duplicate requests: if several people request the same feature, the requests often get…
Pancreatitis history and the risk calculus Replied, post #8 · Safety › Contraindications · 7 May 2026 · 12 likes Worth separating two things that post #6 runs together. Somebody's condition being on a list does not settle the decision, and somebody's condition being absent from…
Journal club: is percentage weight change the right endpoint? Replied, post #111 · Evidence › Journal club · 28 Apr 2026 · 0 likes On post #109 — agreed on the reasoning, with one qualification. Sessions on negative or null results are consistently the most instructive and the hardest to get anyone…
Managing an unplanned gap in supply Replied, post #107 · Access › Shortages · 22 Apr 2026 · 6 likes Following this. I have the same question and no better information than the first post.
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #38 · Compounds › Repair & healing peptides · 16 Apr 2026 · 10 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #25 · Evidence › Preprints · 6 Apr 2026 · 22 likes Where a preprint contradicts a published trial, the prior should favour the trial. Where it extends one, the preprint can be genuinely useful.
Revisiting: Drawing up with one needle and injecting with another Replied, post #54 · Practice › Administration · 6 Apr 2026 · 13 likes Coming back to post #52, because the follow-up matters more than the original answer. A site rotation scheme that actually works: abdomen, outer thigh, back of arm,…
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #40 · Practice › Administration · 4 Apr 2026 · 4 likes Understood, and I withdraw the assumption I opened with.
Grapefruit: why this class is not the class that cares Replied, post #87 · Practice › Interactions · 27 Mar 2026 · 0 likes Small correction to my own earlier position on grapefruit. I had the units the wrong way round, which changes the conclusion by an order of magnitude and therefore…
The "under review" status pill and when a moderator applies it Replied, post #12 · Evidence › Preprints · 8 Mar 2026 · 4 likes The honest position on most preprints in this field is that they are interesting and provisional, and that saying both is not fence-sitting. Two people can read the…
Measurement error in home scales, with a worked standard deviation Replied, post #20 · Research Methods › Statistics · 8 Mar 2026 · 0 likes Time-to-event analysis handles differing follow-up in a way a simple proportion cannot, which is why event rates and Kaplan-Meier estimates can differ. This is the…
An ABAB design with a data table and honest limitations — a second dataset Replied, post #26 · Research Methods › N-of-1 designs · 2 Mar 2026 · 0 likes Designing a personal experiment that could actually change your mind: that is the standard for an n-of-1 design. An experiment designed so that any result confirms what…
Personal import allowances, compared — a second dataset Replied, post #75 · Access › International · 25 Feb 2026 · 9 likes Post #74 is the version of this I will quote in future. One addition. Import rules for personal use: what you can import for personal use depends on your country's…
Pregnancy and pregnancy planning: contraindication and washout Replied, post #51 · Clinical › Special populations · 22 Feb 2026 · 0 likes What I can speak to on pregnancy and pregnancy planning is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #63 · Practice › Dosing & titration · 18 Feb 2026 · 8 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #69 · Sourcing › Vendor reports · 13 Feb 2026 · 0 likes Post #67 and I disagree about the size of the effect, not about the direction. Reports of ordinary results are more valuable than reports of remarkable ones, precisely…
Why this subcategory is stricter about sourcing than most Started this topic · Compounds › Secretagogues & GH axis · 12 Feb 2026 · 6 likes Asking directly, because I could not find a straight answer: Why this subcategory is stricter about sourcing than most A comparison question rather than a question…
Second pass at: Metformin co-administration and additive GI effects Replied, post #46 · Practice › Interactions · 7 Feb 2026 · 2 likes Everything in post #44 holds. The case it does not cover is the one I have. The arithmetic on Metformin co-administration is the easy part and it is where the errors…
Trifluoroacetate content and its consequences Replied, post #104 · Analytics › Impurities & related substances · 7 Feb 2026 · 0 likes I think the trifluoroacetate content question is answerable and has not been answered, which is a more optimistic position than most of this thread.
[2026 update] What a good consultation looks like from the other side Replied, post #15 · Clinical › Prescriber conversations · 7 Feb 2026 · 3 likes The arithmetic in post #12 is right; the assumption feeding it is the part to check. Bringing a record of symptoms with dates and severities makes an assessment…
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #43 · Practice › Interactions · 29 Jan 2026 · 0 likes I have no financial interest in anything named in this thread and I want to say so before I comment on Common supplements, because it is the sort of subject where it…
Interpreting a result that disagrees with the supplier's certificate Replied, post #96 · Sourcing › Independent verification · 26 Jan 2026 · 14 likes The arithmetic on interpreting a result is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #81 · Clinical › Special populations · 25 Jan 2026 · 0 likes My position on Pregnancy and pregnancy planning is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #64 · Clinical › Special populations · 24 Jan 2026 · 17 likes Following this. I have the same question and no better information than the first post.
Heterogeneity as information rather than as a nuisance Replied, post #71 · Evidence › Meta-analyses · 21 Jan 2026 · 0 likes Post #67 describes the usual case. This is about the unusual one. Adding the boring version of heterogeneity, because the interesting version keeps getting posted and…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #81 · Clinical › Special populations · 21 Jan 2026 · 22 likes Dedicated trials in under-studied populations are the only real remedy and several are ongoing, which is worth saying rather than speculating. A partial answer, offered…
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #35 · Devices › Pens & autoinjectors · 29 Dec 2025 · 0 likes A pen that will not dial to the intended dose is usually telling you the cartridge does not contain enough for it. That is a designed behaviour rather than a fault.
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #94 · Compounds › Oral incretins · 16 Dec 2025 · 6 likes Where I part company with post #92, and it is a narrow parting. On variability: the between-person spread in exposure for oral semaglutide is wide enough that two…
Sulfonylureas: the interaction most worth taking seriously Started this topic · Practice › Interactions · 14 Dec 2025 · 19 likes Sulfonylureas: the interaction most worth taking seriously Writing it up because I had to work it out twice and would rather nobody else did. An honest uncertainty…
Run-in periods and the population they select Replied, post #35 · Evidence › Trials · 14 Dec 2025 · 24 likes The documentation on run-in periods is better than this thread and I say that as someone who has posted in the thread.
DXA precision and the least significant change for lean mass Replied, post #59 · Outcomes › Body composition · 11 Dec 2025 · 1 like A request rather than an answer: could whoever has the primary source for DXA precision post it? I have seen the claim three times this month and each version had lost…
Tracking a preprint to publication: a worked example Replied, post #81 · Evidence › Preprints · 8 Dec 2025 · 5 likes Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and have DOIs even if they are later published elsewhere.…
Cross-border purchase rules within the EU Replied, post #49 · Regional › European Union · 4 Dec 2025 · 2 likes Adding the measurement that post #46 says would settle it. What I would want before treating cross-border purchase rules within as settled: the method, the sample, and…
Coming back to: Injection-site reactions: describing them precisely enough to be useful Replied, post #21 · Practice › Side effects · 25 Nov 2025 · 20 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
Robustness: the parameters worth deliberately varying Replied, post #13 · Analytics › Method validation · 21 Nov 2025 · 3 likes Precision has two levels worth distinguishing: repeatability within a run and intermediate precision across days, analysts and instruments. The second is where most…
Lurking for two months before posting: was that the right call? Replied, post #69 · Start Here › Welcome · 21 Nov 2025 · 0 likes Reading rather than answering, but this is the post I would point somebody at.
Pen dose counters: what a click does and does not guarantee Replied, post #117 · Devices › Pens & autoinjectors · 20 Nov 2025 · 20 likes Two people in this thread mean different things by pen dose counters and are disagreeing about the definition while believing they are disagreeing about the facts.…
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #95 · Compounds › Tirzepatide · 17 Nov 2025 · 0 likes Adding a note of thanks rather than an opinion. I did not know most of that.
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #76 · Compounds › Tirzepatide · 15 Nov 2025 · 3 likes The bit of tirzepatide titration schedules that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is…
[2026 update] What steady state means for the decision to escalate Replied, post #89 · Practice › Dosing & titration · 14 Nov 2025 · 10 likes I think the steady state question is answerable and has not been answered, which is a more optimistic position than most of this thread.
Long-time reader, first-time poster Replied, post #10 · Lounge › Introductions · 9 Nov 2025 · 18 likes On long-time reader: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply…
Trust level 3 requirements: a clarification Replied, post #15 · Meta › Announcements · 5 Nov 2025 · 0 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
Payment mechanics and the recovery options that do not exist Replied, post #49 · Sourcing › Payments · 21 Oct 2025 · 0 likes Everything in post #47 holds. The case it does not cover is the one I have. Chargeback reality: if you pay by credit card and the supplier does not deliver, you can…
Second pass at: The mass-error checker and its intended scope Replied, post #42 · Data & Tools › Calculators · 19 Oct 2025 · 8 likes On post #38 — agreed on the reasoning, with one qualification. Mass-error checker has been discussed here with more heat than it deserves, mostly because two…
Micronutrient adequacy at low total intake — does this still hold? Replied, post #15 · Nutrition & Training › Protein & intake · 6 Oct 2025 · 26 likes Post #13 put the caveat in the right place and I want to underline it. I would put moderate confidence on the mainstream reading of Micronutrient adequacy and no more.…
Insurance and replacement policies, compared — the long version Replied, post #23 · Sourcing › Logistics · 5 Oct 2025 · 10 likes I read post #19 twice before replying, because I had assumed the opposite. Speaking only to Insurance and replacement policies as I have actually seen it, rather than…
Non-inferiority margins: how they are chosen and how they are abused Replied, post #4 · Evidence › Trials · 4 Oct 2025 · 0 likes Post #2 put the caveat in the right place and I want to underline it. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #26 · Practice › Interactions · 3 Oct 2025 · 0 likes A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription tells you nothing about whether it interacts. The paperwork is…
Waist circumference technique and its repeatability Replied, post #4 · Outcomes › Progress reports · 3 Oct 2025 · 0 likes Waist circumference technique came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
Follow-up: Why appetite effects are mostly central Replied, post #51 · Pharmacology › Receptor biology · 26 Sep 2025 · 10 likes Worth separating appetite effects as a question about the compound from appetite effects as a question about the documentation. They get answered by different people…
Titles that describe the question, not the situation — what changed since Replied, post #30 · Start Here › How to Ask · 20 Sep 2025 · 9 likes Everything in post #28 holds. The case it does not cover is the one I have. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact…
Critiquing an observational claim about a class effect — one year on Replied, post #5 · Evidence › Study critique · 17 Sep 2025 · 12 likes Everything in post #3 holds. The case it does not cover is the one I have. Per-protocol and intention-to-treat analyses answer different questions and neither is the…
Follow-up: History of disordered eating and why it changes the conversation Replied, post #82 · Clinical › Special populations · 16 Sep 2025 · 13 likes Gastroparesis: pre-existing severe delayed gastric emptying can worsen with compounds that slow it further. Discussion with a clinician is prudent if this history exists.
The nausea timeline across the first four weeks, with a tabulated log Replied, post #38 · Practice › Side effects · 5 Sep 2025 · 3 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
Can a home kit substitute for a laboratory report? A careful no Replied, post #5 · Analytics › Home & field testing · 1 Sep 2025 · 4 likes Useful. I had the fact and not the reason, which turns out to be the important half.
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #57 · Evidence › Journal club · 29 Aug 2025 · 5 likes Post #53 put the caveat in the right place and I want to underline it. Orforglipron phase 2 is a question about a distribution, not about a value, and treating it as a…
Pooling trials with different estimands — what changed since Replied, post #16 · Evidence › Meta-analyses · 23 Aug 2025 · 0 likes When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention, or outcome, pooling them produces a number that represents…
When a preprint is the best available evidence and we say so Replied, post #69 · Evidence › Preprints · 18 Aug 2025 · 22 likes Building on post #66 rather than restating it. Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #26 · Evidence › Journal club · 17 Aug 2025 · 0 likes On post #24 — agreed on the reasoning, with one qualification. I disagree with the framing of orforglipron phase 2 above, and I think it is a substantive disagreement…
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #41 · Practice › Reconstitution · 9 Aug 2025 · 7 likes I read post #39 twice before replying, because I had assumed the opposite. On Over-dilution I would separate what is worth knowing from what is worth acting on. The…
Coming back to: What published stability data actually covers, and what it does not Replied, post #103 · Practice › Storage & stability · 3 Aug 2025 · 0 likes Clear enough that I do not think I have a follow-up, which is unusual.
A field-by-field walk through a certificate of analysis Replied, post #147 · Analytics › COA interpretation · 18 Jul 2025 · 28 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
Hepatic steatosis: what the MASH trial evidence supports Replied, post #83 · Clinical › Comorbidities · 5 Jul 2025 · 0 likes Where two conditions pull in opposite directions, that is a clinical judgement rather than a lookup, and it is the kind of question a forum answers worst. Take it as a…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #42 · Data & Tools › Calculators · 4 Jul 2025 · 1 like Whatever the answer on titration planner refuses turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite…
Coming back to: Resolution and tailing factor: real acceptance criteria Started this topic · Analytics › HPLC & UHPLC · 1 Jul 2025 · 20 likes Posting this under the heading it deserves: Resolution and tailing factor: real acceptance criteria Everything below is what sits behind that. Reading back through what…
Repeatability versus intermediate precision Replied, post #24 · Analytics › Method validation · 20 Jun 2025 · 5 likes The most useful single question about a method: what would it fail to detect? Every method has an answer and few documents state it.
Repeatability versus intermediate precision Replied, post #8 · Analytics › Method validation · 17 Jun 2025 · 19 likes Post #7 is the version of this I will quote in future. One addition. The version of repeatability versus intermediate precision that circulates here is a simplification…
What a 2 ppm match establishes, and what it does not Replied, post #25 · Analytics › Mass spectrometry · 13 Jun 2025 · 7 likes Post #22 is right about the mechanism and I think understates the practical bit. Mass accuracy is expressed in parts per million. It is the difference between observed…
A claim built entirely on a subgroup analysis Replied, post #60 · Evidence › Study critique · 28 May 2025 · 1 like I had read the opposite somewhere and cannot now find where, which tells me something.
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #91 · Compounds › Tirzepatide · 22 May 2025 · 20 likes The confident answers on tirzepatide in type 2 diabetes and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading…
Second pass at: Designing a personal experiment that could change your mind Replied, post #43 · Research Methods › N-of-1 designs · 22 May 2025 · 14 likes The interesting personal experiments are the ones where the answer was no. They are also the ones least likely to be written up. A single observation, in a thread that…
Follow-up: Documentation that appears only after payment Replied, post #52 · Sourcing › Red flags · 6 May 2025 · 9 likes Nothing to add on the substance. Thank you for taking the question at face value.
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #106 · Compounds › Semaglutide · 6 May 2025 · 0 likes This follows post #104 rather than contradicting it. Research-use-only semaglutide is not a licensed medicine, is not manufactured to pharmaceutical standards, and is…
Reconstituting a multi-strength kit without mixing yourself up Replied, post #66 · Practice › Reconstitution · 4 May 2025 · 1 like Picking up post #65: that is the part I would want checked first. A note on how reconstituting a multi-strength kit gets discussed rather than on reconstituting a…
When to stop reading forums, including this one — the long version Replied, post #7 · Wellbeing › Mental health · 2 May 2025 · 7 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
Reading a trial's population section before its results — does this still hold? Replied, post #40 · Evidence › Trials · 25 Apr 2025 · 7 likes Coming back to post #38, because the follow-up matters more than the original answer. A trial that answers a slightly different question from the one you have is the…
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #45 · Practice › Interactions · 12 Apr 2025 · 18 likes Post #42 is right about the mechanism and I think understates the practical bit. Oral medications with a narrow therapeutic index are the ones where that matters most.…
Shakes versus food: a pragmatic assessment — the long version Started this topic · Nutrition & Training › Protein & intake · 12 Apr 2025 · 0 likes On the subject in the title: Shakes versus food: a pragmatic assessment — the long version Working notes rather than a conclusion. A narrow question about Shakes versus…
[2026 update] Mood changes: monitoring, and when to involve a professional Replied, post #5 · Wellbeing › Mental health · 27 Mar 2025 · 5 likes The arithmetic in post #3 is right; the assumption feeding it is the part to check. I changed my mind about Mood changes after someone here asked me for the source and…
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #126 · Access › International · 27 Mar 2025 · 10 likes Customs practice varies between entry points within the same country, which is why two people in the same jurisdiction report different experiences honestly.
Talking to a therapist about this specifically — does this still hold? Replied, post #34 · Wellbeing › Mental health · 24 Mar 2025 · 10 likes Post #33 and I disagree about the size of the effect, not about the direction. Social and relationship impacts: weight change affects how others perceive and interact…
Counter-ion form: the field almost nobody reports — one year on Replied, post #116 · Analytics › COA interpretation · 23 Mar 2025 · 0 likes Everything in post #112 holds. The case it does not cover is the one I have. The signature block matters more than it appears to. A named individual with a date is a…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #111 · Sourcing › Regulatory · 22 Mar 2025 · 22 likes Saving this. It is the version I will quote when the question comes round again.
Validating a method you did not develop — does this still hold? Replied, post #132 · Analytics › Method validation · 18 Mar 2025 · 6 likes Reading rather than answering, but this is the post I would point somebody at.
Validating a method you did not develop — does this still hold? Replied, post #103 · Analytics › Method validation · 12 Mar 2025 · 0 likes Narrowing post #100, because the general version has more than one answer. Transfer between laboratories: a method can be transferred from one lab to another, but the…
Follow-up: What other technical communities get right that we do not Replied, post #37 · Lounge › Off topic · 12 Mar 2025 · 25 likes Personal stories: if you want to talk about what led you to this compound, your journey, or how the change has affected your life, the Lounge is the place for that.
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #65 · Devices › Cold chain · 11 Mar 2025 · 31 likes Temperature loggers in the parcel exist and are occasionally used for high-value shipments. They are the only thing that turns an argument about transit into a record.…
Cost per milligram, computed honestly across formats — the long version Replied, post #28 · Access › Pricing · 8 Mar 2025 · 19 likes The most useful pricing posts here are the ones that show the arithmetic rather than the conclusion. This is the sort of thing the wiki should carry and currently does…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #81 · Compounds › Semaglutide · 28 Feb 2025 · 2 likes Speaking only to published dose-response for semaglutide as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the…
Consistent declarations and why they matter more than clever ones Replied, post #95 · Sourcing › Logistics · 27 Feb 2025 · 0 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing. The answer changed when I changed…
How compounding permissions changed when supply normalised Replied, post #21 · Sourcing › Regulatory · 19 Feb 2025 · 0 likes If you can confirm or contradict a position for your own region, please date the answer. An undated regional claim is the least useful thing in this category.
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #29 · Compounds › Oral incretins · 12 Feb 2025 · 20 likes Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose is not equivalent to any injectable dose in the traditional comparison…
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #49 · Practice › Side effects · 11 Feb 2025 · 23 likes Picking up post #48: that is the part I would want checked first. Taking nausea timeline seriously for a moment rather than deflecting: the honest position is that the…
Canadian access and provincial variation Replied, post #60 · Regional › North America · 6 Feb 2025 · 17 likes Where a manufacturer runs a direct supply route, that is a commercial arrangement rather than a regulatory change, and it can end. It is the kind of thing that is…
Coming back to: Official shortage notices and what they authorise Started this topic · Access › Shortages · 3 Feb 2025 · 13 likes Official shortage notices and what they authorise — setting out what I have, and where I think it stops being reliable. Official shortage notices — I have the…
Identical chromatograms across two different lots Replied, post #75 · Sourcing › Red flags · 12 Jan 2025 · 33 likes Counterpoint on identical chromatograms, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull…
Oxidation pathways for methionine and tryptophan Replied, post #51 · Analytics › Impurities & related substances · 30 Dec 2024 · 7 likes What I would want before treating oxidation pathways for methionine as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the…
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #8 · Evidence › Meta-analyses · 20 Dec 2024 · 8 likes Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the criteria are too broad, apples and oranges get pooled. If they are…
Washout with a one-week half-life: the arithmetic Replied, post #95 · Research Methods › N-of-1 designs · 9 Dec 2024 · 0 likes Clear enough that I do not think I have a follow-up, which is unusual.
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #51 · Evidence › Journal club · 5 Dec 2024 · 23 likes Post #50 is right about the mechanism and I think understates the practical bit. On SURPASS-2, I would rather understate and be corrected upward than overstate and be…
Why "any advice?" is the least effective ending for a post Replied, post #101 · Start Here › How to Ask · 3 Dec 2024 · 3 likes This follows post #98 rather than contradicting it. Say what you have already ruled out. "It is not the diluent because I tried a second vial from a different box"…
The topic list is dense — is that deliberate? Replied, post #61 · Meta › Site feedback · 3 Dec 2024 · 1 like The most useful thing anyone has posted about topic list in this category was a table of what had been measured and by whom. That is what I would want again.
Revisiting: Moderation log format change Replied, post #49 · Meta › Announcements · 1 Dec 2024 · 21 likes Post #47 describes the usual case. This is about the unusual one. Supportive, with one reservation worth stating in public: the change makes a common case slightly…
[2026 update] How to read a forest plot, properly, from scratch Replied, post #7 · Evidence › Trials · 28 Nov 2024 · 4 likes Reading rather than answering, but this is the post I would point somebody at.
Turnaround times and what they mean for a decision — one year on Replied, post #17 · Sourcing › Independent verification · 27 Nov 2024 · 25 likes Cross-checking one lot with two services independently is the cleanest test available and is rarely done because it costs twice as much.
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #44 · Meta › Wiki maintenance · 22 Nov 2024 · 28 likes On revision dispute resolved the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Request: a diff view for wiki revisions Replied, post #25 · Meta › Feature requests · 20 Nov 2024 · 29 likes Tradeoffs: every feature has a cost in maintenance and complexity. Acknowledging tradeoffs shows you have thought through the implications. Adding it in case it saves…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #95 · Clinical › Prescriber conversations · 8 Nov 2024 · 0 likes Take the actual numbers and the actual dates. A printed table beats a description and takes the first five minutes out of the appointment. The mechanism is plausible,…
[2026 update] Comparing tirzepatide and semaglutide is harder than the tables suggest Replied, post #3 · Compounds › Tirzepatide · 4 Nov 2024 · 30 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #140 · Clinical › Bloodwork · 24 Oct 2024 · 22 likes Building on post #137 rather than restating it. I keep a log for bring a laboratory specifically because my memory of it turned out to be systematically wrong in one…
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #13 · Meta › Wiki maintenance · 20 Oct 2024 · 17 likes Small structural suggestion: the worked examples belong before the general statement rather than after it. Everyone I have watched use this page scrolls straight to the…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #107 · Clinical › Bloodwork · 14 Oct 2024 · 13 likes That is a fair summary of where the discussion has got to.
Second pass at: Hoarding and why it makes a shortage worse Replied, post #113 · Access › Shortages · 13 Oct 2024 · 30 likes Everything in post #109 holds. The case it does not cover is the one I have. Anyone reporting availability should say the region and the date, because both determine…
Promotion criteria, and the one that stops most nominations Replied, post #69 · Documentation › Doc review · 24 Sep 2024 · 0 likes Careful with the language on promotion criteria. "Not detected" and "not present" are different findings and the first is a statement about the method.
Circumference measurements as a poor man's composition estimate Replied, post #26 · Outcomes › Body composition · 28 Jul 2024 · 25 likes The most useful protocol is the one you will actually repeat identically. An imperfect measurement repeated consistently beats a better one repeated carelessly. Someone…
Guidelines revision: what changed and why Replied, post #45 · Meta › Announcements · 26 Jul 2024 · 14 likes Worth saying publicly: stepping back cleanly and handing over is a service. Documents with an absent maintainer go wrong quietly, which is the worst way for them to go…
Second pass at: Journal club: LEADER as the historical anchor Replied, post #59 · Evidence › Journal club · 24 Jul 2024 · 4 likes Second this, and I would have said it less carefully.
Second pass at: Retatrutide dose escalation in the published trials Replied, post #13 · Compounds › Retatrutide · 16 Jul 2024 · 16 likes Dose-response in the phase 2 obesity work was clear across the studied range, with no obvious plateau within it. Extrapolating beyond the highest studied dose from that…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #53 · Practice › Dosing & titration · 8 Jul 2024 · 27 likes Nothing to add on the substance. Thank you for taking the question at face value.
Second pass at: Journal club: LEADER as the historical anchor Replied, post #5 · Evidence › Journal club · 6 Jul 2024 · 7 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.
How this community labels and discusses unrefereed work Replied, post #46 · Evidence › Preprints · 28 Jun 2024 · 30 likes Sample size and pre-registration are checkable in a preprint exactly as in a paper, and they carry the same weight.